IBS and IBD both cause digestive discomfort, but one is a functional disorder and the other is a serious inflammatory disease. Learn the key differences in symptoms, diagnosis, and treatment.
The FDA enforces stricter bioequivalence standards for narrow therapeutic index (NTI) drugs like warfarin, digoxin, and phenytoin, requiring tighter limits (90-111%) and replicate studies to ensure patient safety. These rules prevent dangerous fluctuations in blood levels that can occur with generics.
Certain allergy medications can trigger sudden, sight-threatening eye pressure spikes in people with narrow-angle glaucoma. Learn which antihistamines are dangerous, what’s safe to take, and how to protect your vision.
Learn how to safely manage blood thinners before and after surgery. Understand when to stop DOACs, when to restart, and why bridging with heparin is no longer standard. Reduce bleeding and clot risks with evidence-based guidelines.
Metformin is safe for many people with liver disease, but not all. Learn how to prevent lactic acidosis, when to avoid metformin, and how to use it safely with fatty liver or cirrhosis.
Patent Term Restoration (PTE) gives drug makers extra patent life to make up for FDA approval delays. Learn how it works, who qualifies, and why it’s controversial.
Severe drug reactions can kill in minutes. Learn the warning signs of anaphylaxis, Stevens-Johnson Syndrome, and other life-threatening reactions-and exactly when to call 911.
Struggling with Clomid resistance? Get into letrozole, gonadotropins, daily habits, and the next steps in fertility when the usual medication just doesn’t cut it.
Sugar and artificial sweeteners both affect appetite and cravings differently. Learn how they impact your brain, hunger hormones, and long-term weight goals - and what actually works to reduce cravings.
Mefenamic acid doesn't directly cause weight gain, but it can lead to temporary water retention and bloating. Learn how to tell the difference and what to do if you notice scale changes.
Insulin biosimilars offer safe, affordable alternatives to branded insulins, with proven effectiveness and cost savings of 15-30%. Learn which ones are available, why adoption is slow, and how patients and providers can make the switch.
